OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
Xiuyuan Zhao, Xiaolin Xu, Qingyun Li
Journal of Neurology (2020) Vol. 268, Iss. 7, pp. 2364-2376
Open Access | Times Cited: 14
Xiuyuan Zhao, Xiaolin Xu, Qingyun Li
Journal of Neurology (2020) Vol. 268, Iss. 7, pp. 2364-2376
Open Access | Times Cited: 14
Showing 14 citing articles:
Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of New Anti-Migraine Drugs—Lasmiditan, Gepants, and Calcitonin-Gene-Related Peptide (CGRP) Receptor Monoclonal Antibodies
Danuta Szkutnik-Fiedler
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1180-1180
Open Access | Times Cited: 86
Danuta Szkutnik-Fiedler
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1180-1180
Open Access | Times Cited: 86
Evidence-based guidelines for the pharmacological treatment of migraine
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access
Raffaele Ornello, Valeria Caponnetto, Fayyaz Ahmed, et al.
Cephalalgia (2025) Vol. 45, Iss. 4
Closed Access
Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials
Bixi Gao, Nan Sun, Yanbo Yang, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 21
Bixi Gao, Nan Sun, Yanbo Yang, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 21
Efficacy and safety of eptinezumab as preventive treatment for episodic/chronic migraine: A systematic review and meta‐analysis
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 11, pp. 1156-1168
Closed Access | Times Cited: 9
Yusak Mangara Tua Siahaan, Vinson Hartoyo, Timotius Ivan Hariyanto
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 49, Iss. 11, pp. 1156-1168
Closed Access | Times Cited: 9
Galcanezumab for the Management of Migraine: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Ahmed Abu‐Zaid, Saud K AlBatati, Abdullah M AlHossan, et al.
Cureus (2020)
Open Access | Times Cited: 9
Ahmed Abu‐Zaid, Saud K AlBatati, Abdullah M AlHossan, et al.
Cureus (2020)
Open Access | Times Cited: 9
Diagnostic protocols and newer treatment modalities for cluster headache
Sakshi Prasad, Abdulrahim Mehadi, Nirja Kaka, et al.
Disease-a-Month (2022) Vol. 68, Iss. 8, pp. 101316-101316
Closed Access | Times Cited: 5
Sakshi Prasad, Abdulrahim Mehadi, Nirja Kaka, et al.
Disease-a-Month (2022) Vol. 68, Iss. 8, pp. 101316-101316
Closed Access | Times Cited: 5
Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine
Linda Al‐Hassany, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2021) Vol. 34, Iss. 3, pp. 330-338
Closed Access | Times Cited: 7
Linda Al‐Hassany, Antoinette MaassenVanDenBrink
Current Opinion in Neurology (2021) Vol. 34, Iss. 3, pp. 330-338
Closed Access | Times Cited: 7
<p>Reducing Episodic Cluster Headaches: Focus on Galcanezumab</p>
Lanfranco Pellesi, Roberto De Icco, Mohammad Al‐Mahdi Al‐Karagholi, et al.
Journal of Pain Research (2020) Vol. Volume 13, pp. 1591-1599
Open Access | Times Cited: 6
Lanfranco Pellesi, Roberto De Icco, Mohammad Al‐Mahdi Al‐Karagholi, et al.
Journal of Pain Research (2020) Vol. Volume 13, pp. 1591-1599
Open Access | Times Cited: 6
The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
Panagiotis Gklinos, Dimos D. Mitsikostas
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 245-245
Open Access | Times Cited: 4
Panagiotis Gklinos, Dimos D. Mitsikostas
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 245-245
Open Access | Times Cited: 4
Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials
Mohamed Sayed Zaazouee, Rokaya Y. Ebrahim, Ghaida’a Al-araj, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access
Mohamed Sayed Zaazouee, Rokaya Y. Ebrahim, Ghaida’a Al-araj, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access
Recomendações Terapêuticas para Cefaleias da Sociedade Portuguesa de Cefaleias – 2021
Elsa Parreira
Sinapse (2021) Vol. 21, Iss. supplement 1, pp. 3-100
Open Access | Times Cited: 2
Elsa Parreira
Sinapse (2021) Vol. 21, Iss. supplement 1, pp. 3-100
Open Access | Times Cited: 2
Migraine
David Moreno‐Ajona, María Dolores Villar Martínez, Calvin Chan, et al.
Elsevier eBooks (2021), pp. 548-589
Closed Access | Times Cited: 1
David Moreno‐Ajona, María Dolores Villar Martínez, Calvin Chan, et al.
Elsevier eBooks (2021), pp. 548-589
Closed Access | Times Cited: 1
Efficacy and safety of galcanezumab for migraine: evidences from direct and indirect comparisons
Xing Wang, Jinlei Song, Chao You
International Journal of Neuroscience (2022) Vol. 133, Iss. 8, pp. 925-933
Closed Access
Xing Wang, Jinlei Song, Chao You
International Journal of Neuroscience (2022) Vol. 133, Iss. 8, pp. 925-933
Closed Access
Efficacy and safety of galcanezumab for preventive treatment of migraine: a systematic review and meta-analysis
Virginia L. Stauffer, Tina M. Oakes, Mallikarjuna Rettiganti, et al.
Journal of Neurology (2021) Vol. 268, Iss. 5, pp. 1980-1980
Open Access
Virginia L. Stauffer, Tina M. Oakes, Mallikarjuna Rettiganti, et al.
Journal of Neurology (2021) Vol. 268, Iss. 5, pp. 1980-1980
Open Access
